Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.

Noriega FR, Wang JY, Losonsky G, Maneval DR, Hone DM, Levine MM.

Infect Immun. 1994 Nov;62(11):5168-72.

2.

Development of an auxotrophic oral live Shigella flexneri vaccine.

Lindberg AA, Kärnell A, Stocker BA, Katakura S, Sweiha H, Reinholt FP.

Vaccine. 1988 Apr;6(2):146-50. Review.

PMID:
2838986
3.
4.

A review of the current status of enteric vaccines.

Levine MM, Noriega F.

P N G Med J. 1995 Dec;38(4):325-31. Review.

PMID:
9522876
5.

Oral shigella vaccines.

Hale TL, Formal SB.

Curr Top Microbiol Immunol. 1989;146:205-11. Review. No abstract available.

PMID:
2659269
6.

Self-experiments with ingestion of various bacteria.

Rédey B.

Acta Microbiol Acad Sci Hung. 1974;21(1-2):45-62. Review. No abstract available.

PMID:
4216252
7.

Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations.

O'Hagan DT.

Clin Pharmacokinet. 1992 Jan;22(1):1-10. Review. No abstract available.

PMID:
1559304
8.

Live versus killed bacterial vaccines.

Edsall G.

Monogr Allergy. 1975;9:231-44. Review. No abstract available.

PMID:
1090808
9.

Alteration of Shigella pathogenicity by other bacteria.

Nakamura M.

Am J Clin Nutr. 1972 Dec;25(12):1441-51. Review. No abstract available.

PMID:
4567439
10.

Progress in immunization against parasitic helminths.

Lloyd S.

Parasitology. 1981 Aug;83(Pt 1):225-42. Review. No abstract available.

PMID:
7022329
Items per page

Supplemental Content

Support Center